Arecor Therapeutics plc (LON:AREC – Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as GBX 102.20 ($1.31) and last traded at GBX 102.20 ($1.31), with a volume of 28546 shares. The stock had previously closed at GBX 113.50 ($1.45).
Arecor Therapeutics Stock Performance
The stock has a market cap of £31.30 million, a PE ratio of -506.65 and a beta of -0.21. The company has a fifty day moving average price of GBX 134.57 and a 200 day moving average price of GBX 145.78. The company has a quick ratio of 6.24, a current ratio of 2.17 and a debt-to-equity ratio of 3.55.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- ESG Stocks, What Investors Should Know
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Golden Cross Stocks: Pattern, Examples and Charts
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Market Cap Calculator: How to Calculate Market Cap
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
